Soroka Innovation Center

Soroka Innovation Center is built around Soroka University Medical Center in Beersheba, the largest hospital in southern Israel and one of the most distinctive clinical environments in the country. The hospital serves a diverse patient population including Bedouin and other communities, and it has accumulated longitudinal datasets that are unusually valuable for healthcare research and commercialization.

The thesis is grounded in the data and population diversity that Soroka represents. The center supports startups using the hospital’s research infrastructure to incubate and validate health technologies, with particular relevance for products whose commercial value depends on real-world evidence across diverse populations. Portfolio activity concentrates on digital health and AI/ML in healthcare, with attention to clinical AI, predictive diagnostics, population health, and chronic disease management. AI is central to the thesis rather than peripheral, and the program is built around the proposition that longitudinal, diverse data is one of the more underutilized assets in global health research.

Checks fall below two hundred and fifty thousand dollars at the Pre-Seed and Seed stages, structured to support startups working with Soroka’s research infrastructure. Geography is anchored in companies engaging with Soroka and the broader Negev research ecosystem, with portfolio companies typically targeting global markets in the US and Europe. The program is positioned as a clinical and research partner that bridges from academic and clinical insight to commercial commercialization, and the structure of engagement reflects that role.

The team operates at the intersection of hospital administration, clinical research, and commercial development. Founders work directly with clinicians, researchers, and program staff, and the engagement is substantive on questions of data access, study design, regulatory pathway, and the translation of clinical insight into a commercial product. The diligence is heavy on clinical and scientific defensibility, with attention to the commercial credibility of the founder team and the realistic path to follow-on funding.

In practice, the value Soroka offers is clinically distinctive. The hospital’s longitudinal datasets, population diversity, and research infrastructure provide a validation environment that is difficult to replicate, particularly for AI products whose generalizability depends on training and evaluation across diverse populations. The program is direct about scope. It does not engage with companies disconnected from Soroka’s clinical and research environment, and it is not a generalist healthcare program. For founders building AI-driven digital health, clinical decision-support, or population health products that need real-world evidence across diverse populations, Soroka Innovation Center is one of the more substantive clinical-origin partners in Israel. The conversations are clinically grounded, the data partnerships are real, and the founders who do well treat the program as a research and validation partnership rather than as a passive capital event.